Are galanin neurons in the retrotrapezoid nucleus involved in cardiorespiratory coupling?

University of Manchester (2010) Proc Physiol Soc 19, PC127

Poster Communications: Are galanin neurons in the retrotrapezoid nucleus involved in cardiorespiratory coupling?

I. J. Llewellyn-Smith1, C. Heesch2, A. Verberne3, G. Etelvino1

1. Cardiovascular Medicine and Physiology, Flinders University, Bedford Park, South Australia, Australia. 2. Dalton Cardiovascular Research Center, University of Missouri, Columbia, Missouri, United States. 3. Medicine, Austin Health, University of Melbourne, Heidelberg, Victoria, Australia.

View other abstracts by:


The neuropeptide galanin (GAL) causes hypotension when injected into the rostral ventrolateral medulla (RVLM). GAL-immunoreactive neurons occur in the retrotrapezoid nucleus (RTN) in the rostral ventral medulla, which is also a key site for the tonic and reflex control of blood pressure; but it is unknown how GAL neurons relate to cardiovascular neurons. In this study, we used Fos-immunoreactivity resulting from drug-induced hypotension to determine whether GAL neurons in the RTN are barosensitive and to examine the relationship of GAL axons to spinally-projecting adrenergic and non-adrenergic neurons in the RVLM. We implanted cannulae into femoral arteries and veins of isoflurane-anesthetized (3% for induction, 2.5% for maintenance) Sprague Dawley rats for recording arterial pressure (MAP) and infusing drugs, respectively. The next day, we treated conscious rats with hydralazine (HDZ, 2mg/ml) or saline (SAL) and perfused them 2 hours later with 4% formaldehyde. In some rats, we injected the lateral horn of segment T3 (under 3% isoflurane anesthesia) with the retrograde tracer, cholera toxin B subunit (CTB), 3-5 days before drug treatment. We used avidin-biotin-peroxidase to localize immunoreactivity for GAL, Fos, PNMT and CTB (where appropriate) in a 1:4 series of brainstem sections. We also made RVLM microinjections of GAL (20 nl or 40 nl of 1 ng/nl in aCSF) in isoflurane-anesthetized rats to confirm its cardiovascular effects. GAL-immunoreactive neurons were identified in the retrotrapezoid nucleus (RTN); an average of 76.6+16.2 of these neurons (14 rats) occurred caudal to the facial nucleus in the RVLM. HDZ produced significant hypotension (71±10 vs 113±10 mmHg) and induced Fos-immunoreactivity in many ventral medullary neurons. Few neurons were Fos-positive after SAL. About 15% of the GAL neurons in the RVLM expressed Fos in response to hypotension (11.0+5.6, n=8 after HDZ vs 0.7+0.8, n=6 after SAL). HDZ also induced Fos in PNMT-positive and PNMT-negative RVLM neurons. About half of the Fos-immunoreactive C1 neurons were closely apposed by GAL terminals. Of Fos-expressing neurons that had transported CTB from the spinal cord, GAL appositions were found mainly on PNMT-positive neurons and only rarely on PNMT-negative neurons. In a separate group of rats (n= 5), microinjecting 40 ng of GAL consistently decreased MAP to about 25 mmHg below baseline whereas vehicle microinjecting did not affect MAP. This study has confirmed that GAL acts as a depressor agent when injected into the RVLM. We have also shown that some GAL neurons in RTN are barosensitive and that GAL axons closely appose bulbospinal barosensitive C1 and non-C1 neurons in the RVLM. These findings suggest that barosensitive GAL-containing RTN neurons could directly innervate vasomotor presympathetic neurons in RVLM. This pathway could be a means of coupling the activity of cardiovascular and respiratory systems.



Where applicable, experiments conform with Society ethical requirements.

Site search

Filter

Content Type